Auxilium Pharma Holds Live Webcasts to View Xiaflex Procedures

Jefferies published its report on Auxilium Pharma AUXL today after AUXL held live webcasts to view two Xiaflex procedures. In its report, Jefferies writes, "For a one-hour introduction, we felt the live webcast provided an excellent clinical introduction to the data for Xiaflex and feedback from two patients and a physician." Jefferies maintains a Buy rating and $36 price target. AUXL closed yesterday at $19.70.